Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for VELSIPITY (etrasimod) in the European Union to treat patients 16 years...
Pfizer Inc., announced the successful completion of its acquisition of Seagen Inc., a global biotechnology company that discovers, develops and commercializes transformative cancer medicines....
IDEAYA Biosciences, Inc, a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced further interim results from its Phase...
Tempus, a leader in artificial intelligence (AI) and precision medicine, today announced a multi-year, strategic collaboration with Pfizer in which the two companies are...
Valneva SE, a specialty vaccine company, and Pfizer Inc. announced that they have entered into an Equity Subscription Agreement and have updated the terms...
